InvestmentUpdated on 6 December 2024
Seed round
About
Neuria develops a “digital Ozempic”—just as effective, but more precise and sustainable, targeting the root cause of cravings.
1. 400k CHF oversubscribed pre-seed in June 2024.
2. Preparing a 3Mio CHF Seed (April 2025) to be pre-commercial in CH and USA.
Stage
- See stage.
Applies to
- Food, Beverages and Agriculture
- Healthcare